CMBA
PRVA icon

C.M. Bidwell & Associates’s Privia Health PRVA Stock Holding History

C.M. Bidwell & Associates’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,470
Closed -$38.4K – 579
2023
Q2 		$38.4K Buy
+1,470
New +$38.8K 0.03% 309
2022
Q3 		– Sell
-7,060
Closed -$206K – 527
2022
Q2 		$206K Sell
7,060
-1,000
-12% -$25.4K 0.16% 111
2022
Q1 		$215K Buy
8,060
+100
+1% +$2.36K 0.14% 145
2021
Q4 		$206K Buy
+7,960
New +$198K 0.13% 157

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

C.M. Bidwell & Associates's PRVA Position: Q3 2023 in Review

C.M. Bidwell & Associates sold out of Privia Health (PRVA) in Q3 2023, closing a stake of 1,470 shares — an estimated $38.4K sold.

C.M. Bidwell & Associates first reported a position in PRVA in Q4 2021 and held it in 4 quarters. The position peaked at $215K in Q1 2022. 218 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

  • C.M. Bidwell & Associates reported no remaining Privia Health position as of Q3 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,470 Privia Health shares in Q3 2023, an estimated $38.4K.
  • C.M. Bidwell & Associates first reported a position in Privia Health in Q4 2021 and held it in 4 quarters.
  • C.M. Bidwell & Associates's Privia Health position peaked at $215K in Q1 2022.
  • 218 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.